The Native American tribe wrapped up in litigation with generic pharmaceutical companies is trying to prove that its arrangement with Allergan (NYSE:AGN) reflects a legitimate move to boost its economy, according to court documents.
The St. Regis Mohawk Tribe of New York found itself it the middle of a controversial deal this year after it agreed to license the patents for a dry eye drug, Restasis, from Allergan in exchange for payments.
